DUBLIN, Ireland--(BUSINESS WIRE)--Jun. 24, 2014-- Further strengthening its broad line of neurovascular products to treat unruptured brain aneurysms, Covidien plc (NYSE:COV) announced the European...
Covidien’s Pipeline™ Flex embolization device is the next advancement in flow diversion in
Designed to divert blood flow away from an aneurysm, the Pipeline Flex device features a braided cylindrical mesh tube that is implanted across the base or neck of the aneurysm. The device cuts off blood flow to the aneurysm, reconstructing the diseased section of the parent vessel. The device is repositionable and designed for even more accuracy and controlled placement1. Among other features, it includes an instant braid release system that makes it even easier to place1.
“The Pipeline Flex embolization device is the next advancement in flow diversion, combining our clinically-proven braid design2 with a new delivery system designed to offer even more accuracy and control when performing these advanced procedures inside the brain,” said
In
The first-generation Pipeline™ embolization device has been used to treat patients in
For more information about the Pipeline device platform, please visit:
www.covidien.com/pipelineinfo
About
1 Covidien Internal Report: Report on File
2 Becske T, Kallmes DF, Saatci I, et al. Pipeline for Uncoilable or Failed Aneurysms: Results from a Multicenter Clinical Trial. Radiology. Published online before print
3
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140623006591/en/
Source:
Vascular Therapies
David T. Young, 508-452-1644
Manager, External Communications
david.young@covidien.com
or
Coleman Lannum, CFA, 508-452-4343
Vice President
Investor Relations
cole.lannum@covidien.com
or
Peter Lucht, 508-452-4168
Vice President, External Communications
Corporate Communications
peter.lucht@covidien.com
or
Todd Carpenter, 508-452-4363
Senior Director
Investor Relations
todd.carpenter@covidien.com